Latest news with #BathBodyWorks
Yahoo
4 days ago
- Business
- Yahoo
The three-year shareholder returns and company earnings persist lower as Bath & Body Works (NYSE:BBWI) stock falls a further 6.5% in past week
Many investors define successful investing as beating the market average over the long term. But if you try your hand at stock picking, you risk returning less than the market. Unfortunately, that's been the case for longer term Bath & Body Works, Inc. (NYSE:BBWI) shareholders, since the share price is down 20% in the last three years, falling well short of the market return of around 57%. Even worse, it's down 13% in about a month, which isn't fun at all. After losing 6.5% this past week, it's worth investigating the company's fundamentals to see what we can infer from past performance. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. To paraphrase Benjamin Graham: Over the short term the market is a voting machine, but over the long term it's a weighing machine. One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price. During the three years that the share price fell, Bath & Body Works' earnings per share (EPS) dropped by 4.3% each year. This reduction in EPS is slower than the 7% annual reduction in the share price. So it seems the market was too confident about the business, in the past. The less favorable sentiment is reflected in its current P/E ratio of 7.50. You can see below how EPS has changed over time (discover the exact values by clicking on the image). We like that insiders have been buying shares in the last twelve months. Even so, future earnings will be far more important to whether current shareholders make money. It might be well worthwhile taking a look at our free report on Bath & Body Works' earnings, revenue and cash flow. What About Dividends? As well as measuring the share price return, investors should also consider the total shareholder return (TSR). Whereas the share price return only reflects the change in the share price, the TSR includes the value of dividends (assuming they were reinvested) and the benefit of any discounted capital raising or spin-off. So for companies that pay a generous dividend, the TSR is often a lot higher than the share price return. In the case of Bath & Body Works, it has a TSR of -14% for the last 3 years. That exceeds its share price return that we previously mentioned. And there's no prize for guessing that the dividend payments largely explain the divergence! A Different Perspective While the broader market gained around 23% in the last year, Bath & Body Works shareholders lost 6.3% (even including dividends). Even the share prices of good stocks drop sometimes, but we want to see improvements in the fundamental metrics of a business, before getting too interested. Longer term investors wouldn't be so upset, since they would have made 8%, each year, over five years. It could be that the recent sell-off is an opportunity, so it may be worth checking the fundamental data for signs of a long term growth trend. It's always interesting to track share price performance over the longer term. But to understand Bath & Body Works better, we need to consider many other factors. Take risks, for example - Bath & Body Works has 3 warning signs (and 1 which can't be ignored) we think you should know about. If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: most of them are flying under the radar). Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
4 days ago
- Business
- Yahoo
The three-year shareholder returns and company earnings persist lower as Bath & Body Works (NYSE:BBWI) stock falls a further 6.5% in past week
Many investors define successful investing as beating the market average over the long term. But if you try your hand at stock picking, you risk returning less than the market. Unfortunately, that's been the case for longer term Bath & Body Works, Inc. (NYSE:BBWI) shareholders, since the share price is down 20% in the last three years, falling well short of the market return of around 57%. Even worse, it's down 13% in about a month, which isn't fun at all. After losing 6.5% this past week, it's worth investigating the company's fundamentals to see what we can infer from past performance. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. To paraphrase Benjamin Graham: Over the short term the market is a voting machine, but over the long term it's a weighing machine. One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price. During the three years that the share price fell, Bath & Body Works' earnings per share (EPS) dropped by 4.3% each year. This reduction in EPS is slower than the 7% annual reduction in the share price. So it seems the market was too confident about the business, in the past. The less favorable sentiment is reflected in its current P/E ratio of 7.50. You can see below how EPS has changed over time (discover the exact values by clicking on the image). We like that insiders have been buying shares in the last twelve months. Even so, future earnings will be far more important to whether current shareholders make money. It might be well worthwhile taking a look at our free report on Bath & Body Works' earnings, revenue and cash flow. What About Dividends? As well as measuring the share price return, investors should also consider the total shareholder return (TSR). Whereas the share price return only reflects the change in the share price, the TSR includes the value of dividends (assuming they were reinvested) and the benefit of any discounted capital raising or spin-off. So for companies that pay a generous dividend, the TSR is often a lot higher than the share price return. In the case of Bath & Body Works, it has a TSR of -14% for the last 3 years. That exceeds its share price return that we previously mentioned. And there's no prize for guessing that the dividend payments largely explain the divergence! A Different Perspective While the broader market gained around 23% in the last year, Bath & Body Works shareholders lost 6.3% (even including dividends). Even the share prices of good stocks drop sometimes, but we want to see improvements in the fundamental metrics of a business, before getting too interested. Longer term investors wouldn't be so upset, since they would have made 8%, each year, over five years. It could be that the recent sell-off is an opportunity, so it may be worth checking the fundamental data for signs of a long term growth trend. It's always interesting to track share price performance over the longer term. But to understand Bath & Body Works better, we need to consider many other factors. Take risks, for example - Bath & Body Works has 3 warning signs (and 1 which can't be ignored) we think you should know about. If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: most of them are flying under the radar). Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Reuters
4 days ago
- Business
- Reuters
Bath & Body Works targets college bookstores to woo young buyers
NEW YORK, Aug 6 (Reuters) - Bath & Body Works (BBWI.N), opens new tab is going to college. Students at hundreds of U.S. universities will soon be able to buy the company's fragrances, candles and other items at campus bookstores, in a departure from the beauty retailer's long-held business model as it tries to lure coveted Gen-Z shoppers. Bath & Body has struck deals with bookstore operators like Barnes & Noble and Follett Corp to set up shops inside some 600 campus stores, where it will sell popular fragrances like Mahogany Teakwood and Champagne Toast, new CEO Daniel Heaf told Reuters. Schools include George Washington University, Boston College and Vanderbilt University. It is the first time that Bath & Body will sell items outside its own stores, but it won't be the last, Heaf said. "This idea of being either a wholesale brand or a direct-to-consumer brand is over," he said, adding that third-party distribution will be key to growth in the future. Boosting sales with Gen-Z is a priority for Heaf, who took the reins in May after a tough year that saw the company's shares removed from the benchmark S&P 500 index. The shares have lost 24% over the last two years, and closed at $28.93 on Tuesday. College bookstores could be fertile ground for gauging what younger buyers want without investing much capital, said Morningstar analyst Jaime Katz. It's also "a way to keep the conversation going with teen girls while they're ... not living with their parents anymore, not going to their usual places anymore," Katz said. An April survey by investment bank Piper Sandler found that, among teens, sales of fragrances were up 22% versus the same time last year, making it the fastest-growing segment in the beauty industry among teen shoppers. Before joining Bath & Body, Heaf held various roles at Nike (NKE.N), opens new tab, including running its direct-to-consumer business, which former CEO John Donahoe leaned heavily into after the pandemic, reducing the apparel brand's reliance on third-party retailers. That direct-to-consumer shift backfired, and Nike has since sought to repair its retail relationships. But analysts have attributed the failure more to a lack of fresh product than to the work of Heaf, whose reputation as an innovator remains solid. Katz believes Bath & Body's $29 share price could be a bargain, noting the company's strong operating margins and limited exposure to tariffs. One challenge Bath & Body faces, she said, is communicating to consumers the breadth of its product line, which ranges from soaps to lip balms to wallflowers. On that front, Heaf hinted that the company may seek to streamline offerings, focusing on the strongest sellers, and ramp up its digital presence. Bath & Body spends 3% to 4% of its revenue on marketing, but Heaf said he would rather concentrate on fewer, but deeper, campaigns to boost brand awareness. "Think about a video on Instagram that tells a story about the product," he said. "Building awareness leads to a delay in purchase, because you're capturing a new consumer. But it works. I've seen it work."
Yahoo
15-07-2025
- Business
- Yahoo
Wilton Resources Full Year 2024 Earnings: Rp48.30 loss per share (vs Rp14.22 loss in FY 2023)
Net loss: Rp126.7b (loss widened by 240% from FY 2023). Rp48.30 loss per share (further deteriorated from Rp14.22 loss in FY 2023). We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. All figures shown in the chart above are for the trailing 12 month (TTM) period Wilton Resources' share price is broadly unchanged from a week ago. It's necessary to consider the ever-present spectre of investment risk. We've identified 4 warning signs with Wilton Resources (at least 3 which are potentially serious), and understanding them should be part of your investment process. — Investing narratives with Fair Values MicroStrategy: Volatile Gamble or Golden Opportunity? By BlackGoat – Community Contributor Fair Value Estimated: $663.00 · 0.3% Overvalued Emerging Markets and Debt Reduction Will Propel Bath & Body Works Forward By Zwfis – Community Contributor Fair Value Estimated: $40.73 · 0.2% Overvalued An amazing opportunity to potentially get a 100 bagger By davidlsander – Community Contributor Fair Value Estimated: $10.00 · 0.1% Undervalued View more featured narratives — Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
